Social Disconnection Study
Role of Synaptic Density in Mediating the Relation Between Social Disconnection and Late-life Suicide Risk
Role of Synaptic Density in Mediating the Relation Between Social Disconnection and Late-life Suicide Risk
Sponsor study identifier
Secondary identifiers
observational
100
1 country
1
Study Start
May 8, 2023
Actual (reported)Primary Completion
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The purpose of this research study is to examine the effect of social connectedness on the brain. Study procedures include one Magnetic Resonance Imaging (MRI) or functional Magnetic Resonance Imaging (fMRI) scan, one Positron Emission Tomography (PET) scan, one Magnetic Resonance Spectroscopy (MRS) scan, an electroencephalogram (EEG), and in-person and phone call follow-ups.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 8, 2023
Actual (reported)November 12, 2024
Actual (reported)November 26, 2024
Actual (reported)February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Social disconnection
Social disconnection composite measure determined by the following: Item #3 - Hamilton Depression Rating Scale (social withdrawal; range = 0-4) Item #12 - Beck Depression Inventory-II (loss of interest in people; range = 0-3) Item #14 - Center for Epidemiologic Studies Depression Scale (feelings of loneliness; range = 0-3) Item #2 - Snaith-Hamilton Pleasure Scale (enjoyment being with family or close friends; range = 0-1) Item #7 - Snaith-Hamilton Pleasure Scale (enjoyment seeing other people's smiling faces; range = 0-1) Item #17 - Profile of Mood States (loneliness; range = 0-4) Higher composite score = greater severity of social disconnection.
enrollment to end of study participation (approximately 1 year)
SV2A density
SV2A density as measured using \[18F\]SDM8 PET imaging.
enrollment to end of study participation (approximately 1 year)
Composite measure of suicide risk
enrollment to end of study participation (approximately 1 year)
Sex
enrollment to end of study participation (approximately 1 year)
Composite measure of suicide risk over time
12-month study period (from scanning to year 1 follow-up)
Participants will be a transdiagnostic sample of older individuals (age 55+ years) with stress disorders without psychosis including individuals with MDD, bipolar disorder, post-traumatic stress disorder (PTSD), dysthymia, and non-psychiatric individuals.
Transdiagnostic sample of older individuals (age 55+ years) with stress disorders without psychosis including individuals with MDD, bipolar disorder, post-traumatic stress disorder (PTSD), dysthymia, and non-psychiatric individuals.
Yale Translational Brain Imaging Program
New Haven, Connecticut, 06510, United States
Blood may be collected for genetic testing of APOE (a gene associated with Alzheimer's disease) and for DNA testing of polymorphisms in genes of interest to mental health.
Irina Esterlis, Ph.D.
Yale University
First Submitted
November 12, 2024
First Posted
November 26, 2024
Study Start
May 8, 2023
Actual (reported)Primary Completion
February 2028
EstimatedContact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
February 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
August 14, 2026
Record last verified: 2026-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: